Latest News

Source: magnific.com  Ask ten UK traders which broker is best and you'll get a range of answers, because the "best" broker genuinely depends on how someone trades. But when you assess brokers against the criteria that matter most to the widest range of UK traders — regulation, track record, execution quality, platform choice and market [...]

The streaming giant just bought back more stock in a single quarter than ever before. But is that a reason to own it?

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined early clinical data for its RNA interference dimer program, progress in the launch of plozasiran and plans for central nervous system and metabolic disease candidates during the Morgan Stanley Global Healthcare Conference. Early Dimer Data

It takes quite a bit of money to get $500 per month in a TFSA if you invest in index funds like the iShares S&P/TSX 60 Index Fund (TSX:XIU).

It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.

The specialty retailer reported a notable insider stock disposition through indirect entities, including a family foundation.

Cybersecurity companies were having a moment on the exchange.

Huntington Bancshares (NASDAQ:HBAN) said it has revised its 2027 earnings outlook as higher-for-longer interest rates, deposit pricing pressure and competition in selected lending categories weigh on net interest margin and loan growth expectations. Speaking at the Barclays 2026 Global Financial Se

Carney’s “energy superpower” plan leans heavily on nuclear power, and Cameco sits right where more reactors meet more uranium demand.

An important franchisee has filed for bankruptcy protection.

They have a knack for increasing their dividends even when facing challenges.

Or are its best days in the rearview mirror?

The disposal was executed under a pre-established Rule 10b5-1 trading plan adopted in August 2025, reducing the insider's direct stake to 56,858 shares.

Ciena (NYSE:CIEN) outlined financial objectives through fiscal 2029, including a target of approximately $14 billion in revenue, gross margins of about 50%, and operating margins of 32% to 35%, as the company expects demand for optical systems and interconnect products to continue outpacing industry

Gemini Space Station stock surged as investors reacted to a new SEC exemption for tokenized stocks.

Nearly all of the gain arrived in the past 12 months. What was behind it is the same factor that cost the memory producer $5.8 billion three years ago.

The insider disposed of 8% of his stake, leaving him with $1.8 million in direct holdings.

Nvidia remains at the epicenter of the AI infrastructure build-out.

Here are three durable businesses offering yields from 1.6% to 5.5%.

Today, Sept. 18, 2026, Wells Fargo cut its rating and price target, citing weaker engagement and content concerns, prompting investors to watch margin trends.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) is expanding its commercial and clinical footprint around RNA interference therapies, with its recently launched triglyceride-lowering treatment REDEMPLO and several pipeline programs targeting cardiometabolic disease, obesity and central nervous system disord

Given its solid financial performance, favourable growth prospects, and a reasonable valuation, the uptrend in CES Energy is set to continue, making it an excellent long-term buy.

I'd buy Energy Transfer and Verizon stocks, and avoid Pfizer.

A new price target has investors sitting up and taking note.

Kinross Gold (TSX:K) has been such an explosive gainer in recent years, but shares are still really cheap!